UnitedHealth Group Inc. (UNH) Issues FY16 Earnings Guidance
UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY16 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of ~$8.00 for the period, compared to the Thomson Reuters consensus estimate of $7.92.
Shares of UnitedHealth Group Inc. (NYSE:UNH) opened at 134.13 on Tuesday. The company has a 50-day moving average price of $136.95 and a 200 day moving average price of $136.65. The stock has a market capitalization of $127.74 billion, a P/E ratio of 20.99 and a beta of 0.57. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $144.48.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The firm earned $46.30 billion during the quarter, compared to the consensus estimate of $46.06 billion. During the same quarter in the previous year, the company posted $1.77 EPS. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Inc. will post $7.90 earnings per share for the current fiscal year.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/unitedhealth-group-inc-unh-issues-fy16-earnings-guidance.html
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a dividend of $0.625 per share. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.86%. UnitedHealth Group’s payout ratio is currently 39.12%.
UNH has been the subject of a number of recent research reports. Jefferies Group restated a buy rating and set a $163.00 target price on shares of UnitedHealth Group in a research report on Sunday. Evercore ISI initiated coverage on UnitedHealth Group in a research report on Thursday, September 22nd. They set a buy rating and a $155.00 target price for the company. Vetr upgraded UnitedHealth Group from a buy rating to a buy rating in a research report on Friday, October 7th. Cowen and Company set a $150.00 target price on UnitedHealth Group and gave the stock a buy rating in a research report on Tuesday, September 6th. Finally, Oppenheimer Holdings Inc. restated an outperform rating and set a $161.00 target price (up previously from $145.00) on shares of UnitedHealth Group in a research report on Friday, July 22nd. One research analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group currently has a consensus rating of Buy and a consensus target price of $155.35.
In related news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.65% of the stock is owned by insiders.
Several large investors have recently modified their holdings of UNH. 1832 Asset Management L.P. acquired a new stake in shares of UnitedHealth Group during the second quarter worth $213,354,000. Bessemer Group Inc. increased its stake in shares of UnitedHealth Group by 934.0% in the second quarter. Bessemer Group Inc. now owns 534,907 shares of the healthcare conglomerate’s stock worth $75,529,000 after buying an additional 483,173 shares in the last quarter. Marshall Wace LLP increased its stake in shares of UnitedHealth Group by 65.9% in the second quarter. Marshall Wace LLP now owns 718,220 shares of the healthcare conglomerate’s stock worth $101,412,000 after buying an additional 285,242 shares in the last quarter. Numeric Investors LLC increased its stake in shares of UnitedHealth Group by 185.5% in the second quarter. Numeric Investors LLC now owns 422,000 shares of the healthcare conglomerate’s stock worth $59,586,000 after buying an additional 274,200 shares in the last quarter. Finally, State of Tennessee Treasury Department increased its stake in shares of UnitedHealth Group by 33.5% in the second quarter. State of Tennessee Treasury Department now owns 993,328 shares of the healthcare conglomerate’s stock worth $140,258,000 after buying an additional 248,994 shares in the last quarter. 85.80% of the stock is currently owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.